Immunological biomarkers associated with survival in a cohort of Argentinian patients with Common Variable Immunodeficiency

2023 Impact Factor; 11.4. In Press - Pre-proof. “This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo add...

Full description

Bibliographic Details
Main Authors: Kahn, Adrián, Luque, Gabriela, Cuestas, Eduardo, Basquiera, Ana, Ricci, Brenda, Schmitz-Abe, Klaus, Charbonnier, Louis-Marie, Benamar, Mehdi, Motrich, Rubén Darío, Chatila, Talal A., Rivero, Virginia E.
Other Authors: https://orcid.org/0000-0002-5772-1285
Format: info:eu-repo/semantics/acceptedVersion
Language:eng
Published: American Academy of Allergy 2024
Subjects:
Online Access:http://hdl.handle.net/11086/553072
https://www.sciencedirect.com/science/article/pii/S2772829324001073
https://www.jaci-global.org/article/S2772-8293(24)00107-3/fulltext
https://doi.org/10.1016/j.jacig.2024.100311
Description
Summary:2023 Impact Factor; 11.4. In Press - Pre-proof. “This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain”. Fuente: Elsevier Inc. on behalf of the American Academy of Allergy. “Este es un archivo PDF de un artículo que ha sufrido mejoras después de su aceptación, como la adición de una portada y metadatos, y formato para facilitar la lectura, pero aún no es la versión definitiva de registro. Esta versión se someterá a correcciones, composición tipográfica y revisión adicionales antes de su publicación en su forma final, pero proporcionamos esta versión para brindar visibilidad temprana del artículo. Tenga en cuenta que, durante el proceso de producción se pueden descubrir errores que podrían afectar el contenido, y todas las medidas legales Se refieren las exenciones de responsabilidad que se aplican a la revista”. Fuente: Elsevier Inc. on behalf of the American Academy of Allergy.